Purchase Order 75D30121P10337

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $126,125.16 firm fixed price purchase order to Biomatters Incorporated, a bioinformatics software company, for the renewal subscription of Geneious Non Commercial Floating Licenses. This purchase order provides specialized genomic analysis software, data management services, and software subscriptions to support the Centers for Disease Control and Prevention's scientific research and disease...

The Centers for Disease Control and Prevention awarded a purchase order to Unique Technology Systems LLC, a woman-owned small business, for $121,527.63 on February 23, 2026, for Geneious Prime Enterprise Academic Yearly Subscription licenses. The order covers 200 seats of software required for validated CLIA test protocols at CDC facilities in Atlanta, Georgia. Performance extends through February 22, 2028. The procurement originated from a pre-solicitation notice posted December 9, 2025,...

The U.S. government awarded a $19,970 firm fixed-price purchase order to Biomatters Incorporated for Geneious licensing. The contract, which was not set-aside for small business or other designated groups, was awarded on September 4, 2018, with an ultimate completion date of September 4, 2019. The award was funded by a civilian federal agency supporting central program planning coordination and support activities, with performance taking place in Newark, New Jersey. Biomatters Incorporated, a...

<p>The CDC Pittsburgh awarded a purchase order to Illumina, Inc. for lab equipment valued at $197,052.50 on August 11, 2022, with an ultimate completion date of August 31, 2027. No set-aside was used. Performance occurs in San Diego, California. The procurement is firm fixed price and covers DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software under Executive Order 14398.</p>

This federal contract award to Biomatters Incorporated, a bioinformatics software company, is for the upgrade of the Geneious software suite. The $6,385 firm-fixed-price purchase order was awarded by the Department of the Interior Fish and Wildlife Service Region 9 Headquarters and has a completion date of January 20, 2018. The contract does not include a set-aside designation. Biomatters Incorporated is the prime contractor and is not associated with any major subcontractors for this award. The...

This is a one-time purchase order for scientific software awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Biomatters Limited, a bioinformatics software company. The award, valued at $6,409.00, is for the acquisition of Biomatters' Geneious software, a suite of molecular biology and genomic analysis tools. The contract does not have a set-aside designation, indicating it was competitively awarded....

The U.S. government awarded a $7,805 firm fixed-price purchase order to Biomatters Incorporated for a Geneious R9 license. The award was issued on September 21, 2015, with an ultimate completion date of October 23, 2015, and was funded by a civilian federal agency within the Southeast Area. The contract was performed in Athens, Georgia, and no set-aside designation was applied to this procurement. Biomatters Incorporated, a bioinformatics software company headquartered in Boston,...

This is a firm-fixed-price purchase order contract awarded by the U.S. Department of Agriculture's Plant Protection and Quarantine program to Graphpad Software, LLC, a for-profit software company based in Boston, Massachusetts. The contract is for the renewal of 19 licenses of the Geneious software, which is a mission-critical data management and analysis program used daily by the Center for Veterinary Biologics. The software is directly related to testing conducted under the Virus-Serum-Toxin...

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $46,172.80 firm fixed price purchase order for Illumina reagents. The place of performance will be Illumina's facility located in Chamblee, Georgia. The period of performance is from February 7, 2023 through August 15, 2023. CDC Pittsburgh is likely procuring the reagents to support its genomic sequencing and bioinformatics programs that help public health agencies detect,...

<p>The Centers for Disease Control and Prevention (CDC) Pittsburgh issued a purchase order to 10X Genomics, Inc. for $104,850.00 on May 30, 2023, with a completion date of June 12, 2027. The order procures 10X Genomics Immune reagents and related consumables for single-cell transcriptomics research. Place of performance is Atlanta, Georgia.</p>